OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 15 citing articles:

Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression
Romil Singh, Sawai Singh Rathore, Hira Khan, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 136

Vaccine Development Throughout History
Amr Hany Saleh, Shahraz Qamar, Aysun Tekin, et al.
Cureus (2021)
Open Access | Times Cited: 65

Ivermectin as a Potential Addition to the Limited Anti-COVID-19 Arsenal: A Double-Blinded Clinical Trial
Mehran Varnaseri, Fatemeh Amini, Ramin Jamshididan, et al.
Jundishapur journal of health sciences (2024) Vol. 16, Iss. 2
Open Access | Times Cited: 4

Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19
Alessandro D. Santin, David Scheim, Peter A. McCullough, et al.
New Microbes and New Infections (2021) Vol. 43, pp. 100924-100924
Open Access | Times Cited: 25

Identification and Development of Therapeutics for COVID-19
Halie M. Rando, Nils Wellhausen, Soumita Ghosh, et al.
mSystems (2021) Vol. 6, Iss. 6
Open Access | Times Cited: 19

Non-effectiveness of Ivermectin on Inpatients and Outpatients With COVID-19; Results of Two Randomized, Double-Blinded, Placebo-Controlled Clinical Trials
Mohammad Sadegh Rezai, Fatemeh Ahangarkani, Andrew Hill, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 12

Potential of Anthelmintic Herbal Drugs against Gastrointestinal Nematodes in Farm Animals: A Review
Soheil Sadr, Pouria Ahmadi Simab, M Sabet Kasaei, et al.
Farm Animal Health and Nutrition (2022) Vol. 1, Iss. 1, pp. 26-30
Open Access | Times Cited: 11

Potential use of ivermectin for the treatment and prophylaxis of SARS-CoV-2 infection
Raquel Cobos‐Campos, Antxon Apiñaniz, Naiara Parraza, et al.
Current Research in Translational Medicine (2021) Vol. 69, Iss. 4, pp. 103309-103309
Open Access | Times Cited: 10

Association of Obesity with COVID-19 Severity and Mortality: A Systemic Review and Meta-Regression
Romil Singh, Sawai Singh Rathore, Hira Khan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 7

Rapid increase of SpO2 on room air for 34 severe COVID-19 patients after ivermectin-based combination treatment: 55-62% normalization within 12-24 hours
Jacqueline C Stone, Pisirai Ndarukwa, David Scheim, et al.
Research Square (Research Square) (2021)
Closed Access | Times Cited: 6

Effect of combined use of ivermectin and colchicine in COVID-19 patients
Rania Gamal El Sayed, Amr Fouad Hafez, Adham Magdy Ahmed Mohammed Haggag, et al.
Egyptian Journal of Anaesthesia (2022) Vol. 38, Iss. 1, pp. 365-372
Open Access | Times Cited: 3

Bias as a source of inconsistency in ivermectin trials for COVID-19: A systematic review
Ariel Izcovich, Sasha Peiris, Martín Ragusa, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2

Respiratory and other systemic complications of coronavirus disease 2019 in adults: A narrative review
Kiran S. Mahapure, Ishita Mehra, Kinza Iqbal, et al.
Hospital Administration and Medical Practices (2023) Vol. 2
Open Access

Association between Ivermectin treatment and mortality in Covid-19: A hospital-based case-control study
Ravikirti, Alok Ranjan, Rajdeep Porel, et al.
Research Square (Research Square) (2022)
Open Access

Page 1

Scroll to top